ZYME FY 2019 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$30M-44.3% YoY

Gross Profit

-$88M-296.3% margin

Operating Income

-$151M-512.1% margin

Net Income

-$145M-492.3% margin

EPS (Diluted)

$-3.83

Cash Flow

Operating Cash Flow

-$82M

Free Cash Flow

-$96M

Stock-Based Comp.

$49M

Balance Sheet

Total Assets

$368M

Total Liabilities

$123M

Stockholders' Equity

$246M

Cash & Equivalents

$128M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$30M	$53M	-44.3%
Gross Profit	-$88M	-$4M	-2140.9%
Operating Income	-$151M	-$33M	-356.7%
Net Income	-$145M	-$37M	-297.8%